UBS O'Connor’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-15,000
Closed -$562K 381
2017
Q4
$562K Buy
+15,000
New +$562K 0.01% 257